test

Alexandra Toohey

@Baker Bros. Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BGNEBeigene, Ltd.
Recent Activity
24.6%
$2.373B
10.569M shares@ $224.51 avg price
INCYIncyte Corporation
Recent Activity
Increased 0.01%
21.06%
$2.032B
30.739M shares@ $66.1 avg price
ACADAcadia Pharmaceuticals Inc.
Recent Activity
6.84%
$659.462M
42.878M shares@ $15.38 avg price
SMMTSummit Therapeutics Inc.
Recent Activity
Increased 5.18%
5.55%
$534.905M
24.425M shares@ $21.91 avg price
MDGLMadrigal Pharmaceuticals, Inc.
Recent Activity
4.35%
$419.047M
1.975M shares@ $212.23 avg price
RVMDRevolution Medicines, Inc.
Recent Activity
3.56%
$343.258M
7.569M shares@ $45.36 avg price
RYTMRhythm Pharmaceuticals, Inc.
Recent Activity
Increased 0.01%
3.48%
$335.21M
6.398M shares@ $52.4 avg price
INSMInsmed Incorporated
Recent Activity
Increased 23.49%
3.35%
$322.362M
4.416M shares@ $73.0 avg price
KYMRKymera Therapeutics, Inc.
Recent Activity
Increased 0.01%
2.95%
$283.787M
5.996M shares@ $47.34 avg price
BCYCBicycle Therapeutics Plc
Recent Activity
2.21%
$212.721M
9.4M shares@ $22.64 avg price